Protein aggregates: Forms, functions and applications

International Journal of Biological Macromolecules

Volumn 97, Issue , 2017, Pages 778-789

  Mukherjee, Joyeeta ^a   Gupta, Munishwar Nath ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Caseins; Crosslinked enzyme aggregates (CLEAs); Enzymes in detergents; Food proteins; Inclusion bodies; Intrinsically disordered proteins; Membrane proteins; Three phase partitioning of proteins

Indexed keywords

AMYLOID; DETERGENT; ENZYME; PROTEIN; PROTEIN AGGREGATE;

ARTICLE; CATALYSIS; CELL INCLUSION; FOOD PROCESSING; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; ANIMAL; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; HUMANS; PROTEIN AGGREGATES; PROTEINS;

EID: 85006320622     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.11.014     Document Type: Article

References (109)

1. [1] Stryer, L., Berg, J.M., Tymoczko, J.L., Biochemistry. fifth ed., 2002, W.H Freeman, New York.
2. [2] Song, J., Why do proteins aggregate? Intrinsically insoluble proteins and dark mediators revealed by studies on insoluble proteins solubilized in pure water. F1000Res, 2, 2013, 94.
3. [3] Uversky, N., Oldfield, C.J., Dunker, A.K., Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 37 (2008), 215–246.
4. [4] Richards, F.M., Vithayathil, P.J., The preparation of subtilisin- modified ribonuclease and the separation of the peptide and protein components. J. Biol. Chem. 234 (1959), 1459–1465.
5. [5] Richards, F.M., Wyckoff, H.W., Ribonuclease-S. Phillips, D.C., Richards, F.M., (eds.) Atlas of Molecular Structures in Biology, 1974, Clarendon Press Oxford.
6. [6] Anfinsen, C.B., Principles that govern the folding of protein chains. Science 181 (1973), 223–230.
7. [7] Crowley, P.B., Golovin, A., Cation-pi interactions in protein-protein interfaces. Proteins 59 (2005), 231–239.
8. [8] Dougherty, D.A., Cation-pi interactions involving aromatic amino acids. J. Nutr. 137 (2007), 1504S–1508S.
9. [9] Uversky, N., Intrinsically disordered proteins from A to Z. Int. J. Biochem. Cell Biol. 43 (2011), 1090–1103.
10. [10] Mittag, T., Kay, L.E., Forman-Kay, J.D., Protein dynamics and conformational disorder in molecular recognition. J. Mol. Recognit. 23 (2010), 105–116.
11. [11] Copley, S.D., Enzymes with extra talents: moonlighting functions and catalytic promiscuity. Curr. Opin. Chem. Biol. 7 (2003), 265–272.
12. [12] Tompa, P., Szasz, C., Buday, L., Structural disorder throws new light on moonlighting. Trends Biochem. Sci. 30 (2005), 484–489.
13. [13] Jeffery, C.J., Moonlighting proteins −an update. Mol. BioSyst. 5 (2009), 345–350.
14. [14] Cramer, W.A., Engelman, D.M., von Heijne, G., Rees, D.c., Forces involved in the assembly and stabilization of membrane proteins. FASEB J. 6 (1992), 3397–3402.
15. [15] von Heijne, G., Membrane proteins: from sequence to structure. Annu. Rev. Biophys. Biomol. Struct. 23 (1994), 167–192.
16. [16] Wallin, E., von Heijne, G., Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci. 7 (1998), 1029–1038.
17. [17] White, S.H., Wimley, W.C., Membrane protein folding and stability: physical principles. Annu. Rev. Biophys. Biomol. Struct. 28 (1999), 319–365.
18. [18] von Heijne, G., The membrane protein universe: what's out there and why bother?. J. Intern. Med. 261 (2007), 543–557.
19. [19] MacCallum, J.L., Tieleman, D.P., Hydrophobicity scales: a thermodynamic looking glass into lipid-protein interactions. Trends Biochem. Sci. 36 (2011), 653–662.
20. [20] Moon, C.P., Fleming, K.G., Side-chain hydrophobicity scale derived from transmembrane protein folding into lipid bilayers. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10174–10177.
21. [21] Heyden, M., Freites, J.A., Ulmschneider, M.B., White, S.H., Dobias, D.J., Assembly and stability of α-helical membrane proteins. Soft Matter 8 (2012), 7742–7752.
22. [22] Mäler, L., Solution NMR studies of peptide-lipid interactions in model membranes. Mol. Membr. Biol. 29 (2012), 155–176.
23. [23] Bowie, J.U., Structural biology. Membrane protein twists and turns. Science 339 (2013), 398–399.
24. [24] Fink, A.L., Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3 (1998), R9–R23.
25. [25] Kopito, R.R., Aggrosomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10 (2000), 524–530.
26. [26] Mukherjee, J., Gupta, M.N., Paradigm shifts in our views on inclusion bodies. Curr. Biochem. Eng. 2 (2015), 1–9.
27. [27] Rather, G.M., Mukherjee, J., Halling, P.J., Gupta, M.N., Activation of alpha chymotrypsin by three phase partitioning is accompanied by aggregation. PLoS One, 7, 2012, e49241.
28. [28] Lovrein, R.E., Goldensoph, C., Anderson, P., Odegard, B., Three phase partitioning (TPP) via T-butanol: enzyme separation from crudes. Burgess, R., (eds.) Protein Purification, Micro to Macro, 1987, Marcel Dekker Inc., New York, 131–148.
29. [29] Dennison, C., Lovrein, R., Three phase partitioning: concentration and purification of proteins. Protein Express. Purif. 11 (1997), 149–161.
30. [30] Rather, G.M., Gupta, M.N., Refolding of urea denatured ovalbumin with three phase partitioning generates many conformational variants. Int. J. Biol. Macromol. 60 (2013), 301–308.
31. [31] Gupta, M.N., Enzyme function in organic solvents. Eur. J. Biochem. 203 (1992), 25–32.
32. [32] Lee, M.Y., Dordick, J.S., Enzyme activation for nonaqueous media. Curr. Opin. Biotechnol. 13 (2002), 376–384.
33. [33] Hudson, E.P., Eppler, R.K., Clark, D.S., Biocatalysis in semi-aqueous and nearly anhydrous conditions. Curr. Opin. Biotechnol. 16 (2005), 637–643.
34. [34] Kastelic, M., Kalyuzhnyi, Y.V., Hribar-Lee, B., Dill, K.A., Vlachy, V., Protein aggregation in salt solutions. Proc. Natl. Acad. Sci. 112 (2015), 6766–6770.
35. [35] Middelberg, A.P.J., O'Neill, B.K., Harvesting recombinant protein inclusion bodies. Subramanian, G., (eds.) Bioseparation and Bioprocessing, Vol II, Processing Quality and Characterization, Economics, Safety and Hygiene, 1998, Wiley-VCH Weinheim.
36. [36] Dalton, A.C., Barton, W.A., Over-expression of secreted proteins from mammalian cell lines. Protein Sci. 23 (2014), 517–525.
37. [37] Middelberg, A.P.J., Preparative protein refolding. Trends Biotechnol. 20 (2002), 437–443.
38. [38] Datta, S., Gautam, S., Gupta, M.N., Microwave assisted solubilisation of inclusion bodies. Sustain. Chem. Process. 1 (2013), 1–7.
39. [39] Raghava, S., Barua, B., Singh, P.K., Das, M., Madan, L., Bhattacharyya, S., Bajaj, K., Gopal, B., Varadarajan, R., Gupta, M.N., Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies. Protein Sci. 17 (2008), 1987–1997.
40. [40] Middelberg, A.P.J., The influence of protein refolding strategy on cost for competing reactions. Chem. Eng. J. 61 (1996), 41–52.
41. [41] Taylor, G., Hoare, M., Gray, D.R., Marston, F.A.O., Size and density of protein inclusion bodies. Biotechnology 4 (1986), 553–557.
42. [42] Middelberg, A.P.J., O'Neill, B.K., David, I., Bogle, L., Snoswell, M.A., A novel technique for the measurement of disruption in high-pressure homogenization: studies on E. coli containing recombinant inclusion bodies. Biotechnol. Bioeng. 38 (1991), 363–370.
43. [43] Kleinig, A.R., Middelberg, A.P.J., On the mechanism of microbial cell disruption in high-pressure homogenisation. Chem. Eng. Sci. 53 (1998), 891–898.
44. [44] Kleinig, A.R., O'Neill, B.K., Middelberg, A.P.J., The effect of homogeniser impact distance on the disruption of Escherichia coli. Biotechnol. Technol. 10 (1999), 199–204.
45. [45] Chen, J., Liu, Y., Li, X., Wang, Y., Ding, H., Ma, G., Su, Z., Cooperative effects of urea and l-arginine on protein refolding. Protein Express Purif. 66 (2009), 82–90.
46. [46] Przybycien, T.M., Pujar, N.S., Steele, L.M., Alternative bioseparation operations: life beyond packed-bed chromatography. Curr. Opin. Biotechnol. 15 (2004), 469–478.
47. [47] Scopes, R.K., Protein Purification, Principles and Practice. third. ed., 1994, Springer New York.
48. [48] Wilkinson, D.L., Harrison, R.G., Predicting the solubility of recombinant proteins in Escherichia coli. Biotechnology 9 (1991), 443–448.
49. [49] Mitraki, A., King, J., Protein folding intermediates and inclusion body formation. Nat. Biotechnol. 7 (1989), 690–697.
50. [50] Wetzel, R., Chrunyk, B.A., Inclusion body formation by interleukin-1 beta depends on the thermal sensitivity of a folding intermediate. FEBS Lett. 350 (1994), 245–248.
51. [51] Vera, A., González-Montalbán, N., Arı́s, A., Villaverde, A., The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol. Bioeng. 96 (2007), 1101–1106.
52. [52] Worrall, D.M., Goss, N.H., The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli. Aust. J. Biotechnol. 3 (1989), 28–32.
53. [53] Tokalidis, K., Dhurjati, P., Millet, J., Beguin, P., Aubert, J.P., High activity of inclusion bodies formed in Escherichia coli overproducing Clostridium thermocellum endoglucanase D. FEBS Lett. 282 (1991), 205–208.
54. [54] Garcia-Fruitos, E., Gonzalez-Montalban, N., Morell, M., Vera, A., Ferraz, R.M., Aris, A., Ventura, S., Villaverde, A., Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb. Cell Fact. 4 (2005), 27–32.
55. [55] Jevsevar, S., Gaberc-Porekar, V., Fonda, I., Podobnik, B., Grdadolnik, J., Menart, V., Production of nonclassical inclusion bodies from which correctly folded protein can be extracted. Biotechnol. Prog. 21 (2005), 632–639.
56. [56] Wang, L., Maji, S.K., Sawaya, M.R., Eisenberg, D., Riek, R., Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol., 6, 2008, e195.
57. [57] Huang, Z., Zhang, C., Chen, S., Ye, F., Xing, X.H., Active inclusion bodies of acid phosphatase PhoC: aggregation induced by GFP fusion and activities modulated by linker flexibility. Microb. Cell Fact. 12 (2013), 25–33.
58. [58] Shah, S., Gupta, M.N., Simultaneous refolding, purification and immobilization of xylanase with multi-walled carbon nanotubes. Biochim. Biophys. Acta (BBA) 1784 (2008), 363–367.
59. 4 nanoparticles for catalyzing transesterification reactions. New J. Chem. 35 (2011), 2551–2556.
60. [60] Clair, N.L.S., Navia, M.A., Crosslinked enzyme crystals as robust biocatalyst. J. Am. Chem. Soc. 114 (1992), 7314–7316.
61. [61] Lalonde, J.J., Navia, M.A., Margolin, A.L., Cross-linked enzyme crystals of lipase as catalyst for kinetic resolution of acids and alcohols. Methods Enzymol. 286 (1997), 443–464.
62. [62] Solanki, K., Gupta, M.N., Halling, P.J., Examining structure activity correlations of some high activity enzyme preparations for low water media. Bioresour. Technol. 115 (2012), 147–151.
63. [63] Nahalka, J., Nidetzky, B., Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilis D-amino acid oxidase as insoluble enzyme aggregates. Biotechnol. Bioeng. 97 (2006), 454–461.
64. [64] Patra, A.K., Mukhopadhyay, R., Mukhija, R., Krishnan, A., Garg, L.C., Panda, A.K., Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from escherichia coli. Protein Expres. Purif. 18 (2000), 182–192.
65. [65] Singh, S.M., Panda, A.K., Solubilization and refolding of bacterial inclusion body proteins. J. Biosci. Bioeng. 99 (2005), 303–310.
66. [66] Taglialegna, A., Lasa, I., Valle, J., Amyloid structures as biofilm matrix scaffolds. J. Bacteriol. 198 (2016), 2579–2588.
67. [67] Pham, C.L., Kwan, A.H., Sunde, M., Functional amyloid: widespread in Nature diverse in purpose. Essays Biochem. 56 (2014), 207–219.
68. [68] Hekmat, D., Hebel, D., Schmid, H., Weuster-Botz, D., Crystallization of lysozyme: from vapor diffusion experiments to batch crystallization in agitated ml-scale vessels. Process Biochem., 42, 2007, 1649.
69. [69] Horne, D.S., Casein micellar structure. Curr. Opin. Coll. Int. Sci. 11 (2006), 148–153.
70. [70] Proteins in Food Processing. Yada, R.Y., (eds.), 2004, Woodhead Publishing Ltd, Cambridge.
71. [71] Smith, K., Industrial uses of soy proteins: new ideas. Inform 7 (1996), 1212–1223.
72. [72] Janeway, C.A., Immunobiology. fifth ed., 2001, Garland Science, New York.
73. [73] Gupta, M.N., Mattiasson, B., Affinity precipitation. Street, G., (eds.) Highly Selective Separations in Biotechnology, 1994, Blackie Academic and Professional, New York, 7–33.
74. [74] Niederauer, M.Q., Glatz, C.F., Selective precipitation. Tsao, G.T., (eds.) Adv. Biochem. Eng., 1992, 159–188 /Biotechnol. Vol. 47, Springer Berlin.
75. [75] Mondal, K., Gupta, M.N., The affinity concept in bioseparation: evolving paradigms and expanding range of applications. Biomol. Eng. 23 (2006), 59–76.
76. [76] Mondal, K., Sharma, A., Gupta, M.N., Macro-(affinity ligand) facilitated three phase partitioning (MLFTPP) for purification of glucoamylase and pullulanase using alginate. Protein Expr. Purif. 28 (2003), 190–195.
77. [77] Mondal, K., Roy, I., Gupta, M.N., Affinity based strategies for protein purification. Anal. Chem. 78 (2006), 3499–3504.
78. [78] Zaks, A., Klibanov, A.M., Enzyme-catalyzed processes in organic solvents. Proc. Natl. Acad. Sci. U. S. A. 82 (1985), 3192–3196.
79. [79] Zaks, A., Klibanov, A.M., Enzymatic catalysis in non-aqueous solvents. J. Biol. Chem. 263 (1988), 3194–3201.
80. [80] Carpenter, J.F., Crowe, J.H., An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. Biochemistry 28 (1989), 3916–3922.
81. [81] Carpenter, J.F., Prestrelski, S.J., Arakawa, T., Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization: i. Enzyme activity and calorimetric studies. Arch. Biochem. Biophys. 303 (1993), 456–464.
82. [82] Roy, M.N., Gupta, Freeze-drying of proteins: some emerging concerns. Biotechnol. Appl. Biochem. 39 (2004), 165–177.
83. [83] Roy Gupta, M.N., Preparation of highly active alpha chymotrypsin for catalysis in organic media. Bioorg. Med. Chem. Lett. 14 (2004), 2191–2193.
84. [84] Shah, S., Gupta, M.N., Kinetic resolution of (+/−)-1-phenylethanol in [Bmim][PF6] using high activity preparations of lipases. Bioorg. Med. Chem. Lett. 17 (2007), 921–924.
85. [85] Majumder, A.B., Gupta, M.N., Increasing catalytic efficiency of Candida rugosa lipase for the synthesis of tert-alkyl butyrates in low water media. Biocatal. Biotransform. 29 (2011), 238–245.
86. [86] Mukherjee, J., Gupta, M.N., Molecular bioimprinting of lipases with surfactants and its functional consequences in low water media. Int. J. Biol. Macromol. 81 (2015), 544–551.
87. [87] Mukherjee, J., Gupta, M.N., Enhancing the catalytic efficiency of subtilisin for transesterification by dual bioimprinting. Tetrahedron 56 (2015), 4397–4401.
88. [88] Gray, C.J., Stabilization of enzymes with soluble additives. Gupta, M.N., (eds.) Thermostability of Enzymes, 1993, Springer-Verlag, Weinheim.
89. [89] Kuznetsova, M., Turoverov, K.K., Uversky, V.N., What macromolecular crowding can do to a protein. Int. J. Mol. Sci. 15 (2014), 23090–23140.
90. [90] van den Berg, B., John Ellis, R., Dobson, C.M., Effects of macromolecular crowding on protein folding and aggregation. EMBO J. 18 (1999), 6927–6933.
91. [91] Privalov, P.L., Cold denaturation of proteins. Crit. Rev. Biochem. Mol. Biol. 25 (1990), 281–305.
92. [92] Introduction to Nanoscience and Nanotechnology. Hornyak, G.L., Tibbals, H.F., Dutta, J., Moore, J.J., (eds.), 2009, CRC Press, Taylor and Francis Group, New York.
93. [93] Eriksson, K., Gelfiltration. Vijayalakshmi, M.A., (eds.) Biochromatography: Theory and Practice, 2002, Taylor and Francis, New York, 9–23.
94. [94] Ami, D., Bonecchi, L., Cali, S., Orsini, G., Tonon, G., Doglia, S.M., FT-IR study of heterologous protein expression in recombinant Escherichia coli strains. Biochim. Biophys. Acta 1624 (2003), 6–10.
95. [95] Ami, D., Natalello, A., Gatti-Lafranconi, P., Lotti, M., Doglia, S.M., Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy. FEBS Lett. 579 (2005), 3433–3436.
96. [96] Ami, D., Natalello, A., Taylor, G., Tonon, G., Doglia, S.M., Structural analysis of protein inclusion bodies by fourier transform infrared microspectroscopy. Biochim. Biophys. Acta 1764 (2006), 793–799.
97. [97] Przybycien, T.M., Dunn, J.P., Valax, P., Georgiou, G., Secondary structure characterization of beta-lactamase inclusion bodies. Prot. Eng. 7 (1994), 131–136.
98. [98] Moran, S.D., Woys, A.M., Buchanan, L.E., Bixby, E., Decatur, S.M., Zanni, M.T., Two-dimensional IR spectroscopy and segmental 13C labeling reveals the domain structure of human gamma D-crystallin amyloid fibrils. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3329–3334.
99. [99] Topilina, N.I., Ermolenkov, V.V., Higashiya, S., Welch, J.T., Lednev, I.K., (-sheet folding of 11-kDa fibrillogenic polypeptide is completely aggregation driven. Biopolymers 86 (2007), 261–264.
100. [100] Xu, M., Ermolenkov, V.V., Uversky, V.N., Lednev, I.K., Hen egg white lysozyme fibrillation: a deep-UV resonance Raman spectroscopic study. J. Biophoton. 1 (2008), 215–229.
101. [101] Ma, S., Cao, X., Mak, M., Sadik, A., Walkner, C., Freedman, T.B., Lednev, I.K., Dukor, R.K., Nafie, L.A., Vibrational circular dichroism shows unusual sensitivity to protein fibril formation and development in solution. J. Am. Chem. Soc. 129 (2007), 12364–12365.
102. [102] Uversky, N., Dunker, A.K., (eds.) Intrinsically Disordered Protein Analysis, Vol. 1, 2012, Humana Press, New York.
103. [103] Hawe, Filipe A., Jiskoot, W., Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm. Res. 27 (2010), 796–810.
104. [104] http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049241#s5. (Supporting information S2-S5) Accessed on 27th November 2015.
105. [105] Gillespie, C., Halling, P., Edwards, D., Monitoring of particle growth at a low concentration of a poorly water soluble drug using the NanoSight LM20. Coll. Surf. A 384 (2011), 233–239.
106. [106] Dragovic, R.A., Gardiner, C., Brooks, A.S., Tannetta, D.S., Ferguson, D.J., Hole, P., Carr, B., Redman, C.W., Harris, A.L., Dobson, P.J., Harrison, P., Sargent, I.L., Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 7 (2011), 780–788.
107. [107] Bednarska, N.G., van Eldere, J., Gallardo, R., Ganesan, A., Ramakers, M., Vogel, I., Baatsen, P., Staes, A., Goethals, M., Hammarström, P., Nilsson, K.P., Gevaert, K., Schymkowitz, J., Rousseau, F., Protein aggregation as an antibiotic design strategy. Mol. Microbiol. 99 (2016), 849–865.
108. [108] Tanaka, M., Komi, Y., Layers of structure and function in protein aggregation. Nat. Chem. Biol. 11 (2015), 373–377.
109. [109] Skrdla, P.J., Roles of nucleation denucleation, coarsening and aggregation kinetics in nanoparticles preparations and neurological diseases. Langmuir 28 (2012), 4842–4857.